Skip to main content

Table 1 Baseline characteristics of study sample (n = 40)

From: Rationale and design of a randomized controlled trial of directly observed hepatitis C treatment delivered in methadone clinics

Sociodemograpic

 

Age, mean (sd)

48 (6.4)

Gender, n (%)

 

   Male

22 (55)

   Female

18 (45)

Race, n (%)a

 

   White

15 (39)

   Black

6 (15)

   Other

18 (46)

Ethnicity, n (%)a

 

   Hispanic

30 (77)

   Non-Hispanic

9 (23)

Education, n (%)

 

   Grade 12/GED or lower

37 (93)

   College (partial or completed)

3 (7)

Marriage Status, n (%)

 

   Married/living with partner

20 (50)

   Widowed/separated/divorced/single

20 (50)

Employed, n (%)a

 

   Employed

4 (11)

   Unable to work/unemployed/other

34 (89)

Housing status, n (%)a

 

   Stable

31 (82)

   Unstable

7 (18)

Psychiatric

 

Psychiatric illness, n (%)b

 

   Current psychiatric illness

26 (65)

   No current psychiatric illness

14 (35)

Depression: Beck Depression Inventory-II, n (%)

 

   BDI 0-19 (none, minimal or mild)

19 (48)

   BDI 20-28 (moderate)

5 (12)

   BDI 29-63 (severe)

16 (40)

Drug and Alcohol Use

 

Alcohol (by AUDIT), n (%)

 

   At risk alcohol (AUDIT ≥ 8)

3 (8)

   Not at risk alcohol (AUDIT < 8)

37 (92)

Self-reported illicit drug use - past 30 days, n (%)

 

   Cocaine/crack within 30 days

9 (23)

   Heroin within 30 days

9 (23)

   Any heroin/cocaine/crack within 30 days

15 (38)

Years of methadone maintenance, median (IQR)

10 (5 - 18)

Median methadone dose - mg, median (IQR)

90 (60 - 140)

HCV-related Factors

 

HCV genotype, n (%)

 

   Genotype 1 or 4

24 (60)

   Genotype 2

9 (23)

   Genotype 3

7 (17)

HCV Viral Load (IU/ml), n (%)

 

   ≥ 800,000 IU/ml

15 (38)

   < 800,000 IU/ml

25 (62)

HIV status, n (%)

 

   HIV-

29 (73)

   HIV+

11 (27)

CD4 (cells/mm3), median (IQR)

476 (356 - 820)

Taking HAART, n (%)

7 (64)

  1. a missing data
  2. b depression, anxiety disorder, psychotic disorder, post-traumatic stress disorder, and/or bipolar disorder